SCHEMBL7815486

SCHEMBL7815486

Cc1cccc2c1C(=O)c1sc(-c3ccccc3)nc1C2=O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 6/20 0.57
TDO2 P48775 4/20 0.57
PTGS2 P35354 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.41
USP8 P40818 1/20 0.41
FGFR1 P11362 1/20 0.40
FGFR2 P21802 1/20 0.40
FGFR4 P22455 1/20 0.40
FGFR3 P22607 1/20 0.40
ALDH1A1 P00352 2/20 0.40
MAPT P10636 2/20 0.40
GAA P10253 1/20 0.40
RARA P10276 1/20 0.40
RARB P10826 1/20 0.40
RARG P13631 1/20 0.40
MAPK14 Q16539 1/20 0.40
ALOX5 P09917 1/20 0.40
CDC7 O00311 1/20 0.39
CCNE1 P24864 1/20 0.39
CDK2 P24941 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7808401 0.95 IDO1 (0.57) IDO1TDO2PTGS2SMN1; SMN2USP8
SCHEMBL7815358 0.85 IDO1 (0.58) IDO1TDO2SMN1; SMN2ALDH1A1MAPT
SCHEMBL7805816 0.83 IDO1 (0.53) IDO1TDO2PTGS2SMN1; SMN2FGFR1
SCHEMBL7808047 0.82 IDO1 (0.79) IDO1TDO2PTGS2ALDH1A1CDC7
SCHEMBL7805852 0.80 ADORA2A (0.41) IDO1TDO2SMN1; SMN2USP8ALDH1A1
SCHEMBL7812573 0.78 IDO1 (0.53) IDO1TDO2PTGS2SMN1; SMN2FGFR1
SCHEMBL7808005 0.76 IDO1 (0.60) IDO1TDO2PTGS2SMN1; SMN2USP8
SCHEMBL7805807 0.76 IDO1 (0.60) IDO1TDO2PTGS2SMN1; SMN2USP8
SCHEMBL22732884 0.75 IDO1 (0.63) IDO1TDO2PTGS2SMN1; SMN2ALDH1A1
SCHEMBL7815082 0.74 ADORA2A (0.41) IDO1TDO2SMN1; SMN2USP8ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876356-B1 USE OF TRICYCLIC 1,4-DIHYDRO-1,4-DIOXO-1H-NAPHTHALENE DERIVATIVES, RESULTING NOVEL COMPOUNDS AND THERAPEUTICAL USE THEREOF INNOTHERA SA LAB (FR) 2001-10-31 EP claimed
EP-0876356-B1 USE OF TRICYCLIC 1,4-DIHYDRO-1,4-DIOXO-1H-NAPHTHALENE DERIVATIVES, RESULTING NOVEL COMPOUNDS AND THERAPEUTICAL USE THEREOF INNOTHERA SA LAB (FR) 2001-10-31 EP disclosed
US-6262095-B1 TREATMENT OF ILLNESS ASSOCIATED WITH AN ALTERATION IN VENOUS FUNCTION AND/OR INFLAMMATORY EDEMA LABORATOIRE INNOTHERA (FR) 2001-07-17 US disclosed